Scott Howell on the Very Large Costs of Drug Utilization Management

Health Affairs Editor-in-Chief Alan Weil interviews Scott Howell, chief strategy officer of US pharmaceuticals at Novartis Pharmaceuticals on drug utilization management and the tension between drug manufacturers and pharmaceutical benefit designs.